Abstract
The relationship between oestrogen (E2) and insulin-like growth factor-one (IGF-1) was examined in both tamoxifen-sensitive (MCF 7/5–21) and tamoxifen-resistant (MCF 7/5–23) subclones of the MCF 7 cell line. Both subclones were grown in defined, serum-free (SF) medium over a period of 7 days with the addition of E2 or IGF-1 or a combination of both agents. Growth of both MCF 7/5–21 and 7/5–23 cells was stimulated (245% and 350%, respectively) by E2. However, only the growth of MCF 7/5–23 cells was stimulated (266%) by IGF-1. A combination of E2 and IGF-1 significantly enhanced MCF 7/5–21 and 7/5–23 cell growth (581% and 695%, respectively). E2-induced IGF-1 receptor (IGF-1R) levels (as measured by 125 I-IGF-1 binding and Northern analyses) in only MCF 7/5–23 cells. This effect was partially inhibited by tamoxifen. In medium containing serum, the growth of only the MCF 7/5–23 cells was significantly inhibited by the IGF-1R monoclonal antibody, αIR-3. The detection of E2-induced expression of IGF-2 using RT-PCR was demonstrated in the MCF 7/5–23 cells. These experiments indicate that E2 may sensitize tamoxifen-resistant MCF 7/5–23 cells to the growth stimulatory actions of IGF-2 via up-regulation of the IGF-1R and describes a cell-survival mechanism that may manifest itself as tamoxifen resistance. © 1999 Cancer Research Campaign
Keywords: breast cancer, IGF-1R, oestrogen, tamoxifen resistance
Full Text
The Full Text of this article is available as a PDF (144.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arteaga C. L., Osborne C. K. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res. 1989 Nov 15;49(22):6237–6241. [PubMed] [Google Scholar]
- Baserga R., Hongo A., Rubini M., Prisco M., Valentinis B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim Biophys Acta. 1997 Jun 7;1332(3):F105–F126. doi: 10.1016/s0304-419x(97)00007-3. [DOI] [PubMed] [Google Scholar]
- Berthois Y., Katzenellenbogen J. A., Katzenellenbogen B. S. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A. 1986 Apr;83(8):2496–2500. doi: 10.1073/pnas.83.8.2496. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
- Clarke R. B., Howell A., Anderson E. Type I insulin-like growth factor receptor gene expression in normal human breast tissue treated with oestrogen and progesterone. Br J Cancer. 1997;75(2):251–257. doi: 10.1038/bjc.1997.41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Darbre P., Yates J., Curtis S., King R. J. Effect of estradiol on human breast cancer cells in culture. Cancer Res. 1983 Jan;43(1):349–354. [PubMed] [Google Scholar]
- Dickson R. B., Johnson M. D., el-Ashry D., Shi Y. E., Bano M., Zugmaier G., Ziff B., Lippman M. E., Chrysogelos S. Breast cancer: influence of endocrine hormones, growth factors and genetic alterations. Adv Exp Med Biol. 1993;330:119–141. doi: 10.1007/978-1-4615-2926-2_10. [DOI] [PubMed] [Google Scholar]
- Dunn S. E., Hardman R. A., Kari F. W., Barrett J. C. Insulin-like growth factor 1 (IGF-1) alters drug sensitivity of HBL100 human breast cancer cells by inhibition of apoptosis induced by diverse anticancer drugs. Cancer Res. 1997 Jul 1;57(13):2687–2693. [PubMed] [Google Scholar]
- Encarnacion C. A., Fuqua S. A. Estrogen receptor variants in breast cancer. Cancer Treat Res. 1994;71:97–109. doi: 10.1007/978-1-4615-2592-9_6. [DOI] [PubMed] [Google Scholar]
- Freiss G., Rochefort H., Vignon F. Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity. Biochem Biophys Res Commun. 1990 Dec 31;173(3):919–926. doi: 10.1016/s0006-291x(05)80873-3. [DOI] [PubMed] [Google Scholar]
- Hu X. F., Veroni M., De Luise M., Wakeling A., Sutherland R., Watts C. K., Zalcberg J. R. Circumvention of tamoxifen resistance by the pure anti-estrogen ICI 182,780. Int J Cancer. 1993 Nov 11;55(5):873–876. doi: 10.1002/ijc.2910550529. [DOI] [PubMed] [Google Scholar]
- Huff K. K., Kaufman D., Gabbay K. H., Spencer E. M., Lippman M. E., Dickson R. B. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res. 1986 Sep;46(9):4613–4619. [PubMed] [Google Scholar]
- Huynh H., Nickerson T., Pollak M., Yang X. Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780. Clin Cancer Res. 1996 Dec;2(12):2037–2042. [PubMed] [Google Scholar]
- Jones J. I., Clemmons D. R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995 Feb;16(1):3–34. doi: 10.1210/edrv-16-1-3. [DOI] [PubMed] [Google Scholar]
- Karey K. P., Sirbasku D. A. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol. Cancer Res. 1988 Jul 15;48(14):4083–4092. [PubMed] [Google Scholar]
- Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., Masushige S., Gotoh Y., Nishida E., Kawashima H. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science. 1995 Dec 1;270(5241):1491–1494. doi: 10.1126/science.270.5241.1491. [DOI] [PubMed] [Google Scholar]
- Katzenellenbogen B. S., Norman M. J. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen. Endocrinology. 1990 Feb;126(2):891–898. doi: 10.1210/endo-126-2-891. [DOI] [PubMed] [Google Scholar]
- Kleinman D., Karas M., Roberts C. T., Jr, LeRoith D., Phillip M., Segev Y., Levy J., Sharoni Y. Modulation of insulin-like growth factor I (IGF-I) receptors and membrane-associated IGF-binding proteins in endometrial cancer cells by estradiol. Endocrinology. 1995 Jun;136(6):2531–2537. doi: 10.1210/endo.136.6.7750475. [DOI] [PubMed] [Google Scholar]
- Kull F. C., Jr, Jacobs S., Su Y. F., Svoboda M. E., Van Wyk J. J., Cuatrecasas P. Monoclonal antibodies to receptors for insulin and somatomedin-C. J Biol Chem. 1983 May 25;258(10):6561–6566. [PubMed] [Google Scholar]
- Lee A. V., Darbre P., King R. J. Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells. Mol Cell Endocrinol. 1994 Mar;99(2):211–220. doi: 10.1016/0303-7207(94)90010-8. [DOI] [PubMed] [Google Scholar]
- Lee A. V., Yee D. Insulin-like growth factors and breast cancer. Biomed Pharmacother. 1995;49(9):415–421. doi: 10.1016/0753-3322(96)82678-3. [DOI] [PubMed] [Google Scholar]
- Lippman M. E. Growth regulation of human breast cancer. Clin Res. 1985 Sep;33(3):375–382. [PubMed] [Google Scholar]
- McCotter D., van den Berg H. W., Boylan M., McKibben B. Changes in insulin-like growth factor-I receptor expression and binding protein secretion associated with tamoxifen resistance and estrogen independence in human breast cancer cells in vitro. Cancer Lett. 1996 Feb 6;99(2):239–245. doi: 10.1016/0304-3835(95)04104-4. [DOI] [PubMed] [Google Scholar]
- Musgrove E. A., Sutherland R. L. Acute effects of growth factors on T-47D breast cancer cell cycle progression. Eur J Cancer. 1993;29A(16):2273–2279. doi: 10.1016/0959-8049(93)90221-z. [DOI] [PubMed] [Google Scholar]
- Newton C. J., Trapp T., Pagotto U., Renner U., Buric R., Stalla G. K. The oestrogen receptor modulates growth of pituitary tumour cells in the absence of exogenous oestrogen. J Mol Endocrinol. 1994 Jun;12(3):303–312. doi: 10.1677/jme.0.0120303. [DOI] [PubMed] [Google Scholar]
- Osborne C. K., Coronado E. B., Kitten L. J., Arteaga C. I., Fuqua S. A., Ramasharma K., Marshall M., Li C. H. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor. Mol Endocrinol. 1989 Nov;3(11):1701–1709. doi: 10.1210/mend-3-11-1701. [DOI] [PubMed] [Google Scholar]
- Papa V., Gliozzo B., Clark G. M., McGuire W. L., Moore D., Fujita-Yamaguchi Y., Vigneri R., Goldfine I. D., Pezzino V. Insulin-like growth factor-I receptors are overexpressed and predict a low risk in human breast cancer. Cancer Res. 1993 Aug 15;53(16):3736–3740. [PubMed] [Google Scholar]
- Parisot J. P., Hu X. F., Sutherland R. L., Wakeling A., Zalcberg J. R., DeLuise M. The pure antiestrogen ICI 182,780 binds to a high-affinity site distinct from the estrogen receptor. Int J Cancer. 1995 Aug 9;62(4):480–484. doi: 10.1002/ijc.2910620420. [DOI] [PubMed] [Google Scholar]
- Pekonen F., Partanen S., Mäkinen T., Rutanen E. M. Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res. 1988 Mar 1;48(5):1343–1347. [PubMed] [Google Scholar]
- Peyrat J. P., Bonneterre J., Hecquet B., Vennin P., Louchez M. M., Fournier C., Lefebvre J., Demaille A. Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer. 1993;29A(4):492–497. doi: 10.1016/s0959-8049(05)80137-6. [DOI] [PubMed] [Google Scholar]
- Quinn K. A., Treston A. M., Unsworth E. J., Miller M. J., Vos M., Grimley C., Battey J., Mulshine J. L., Cuttitta F. Insulin-like growth factor expression in human cancer cell lines. J Biol Chem. 1996 May 10;271(19):11477–11483. doi: 10.1074/jbc.271.19.11477. [DOI] [PubMed] [Google Scholar]
- Reddel R. R., Alexander I. E., Koga M., Shine J., Sutherland R. L. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells. Cancer Res. 1988 Aug 1;48(15):4340–4347. [PubMed] [Google Scholar]
- Resnicoff M., Abraham D., Yutanawiboonchai W., Rotman H. L., Kajstura J., Rubin R., Zoltick P., Baserga R. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 1995 Jun 1;55(11):2463–2469. [PubMed] [Google Scholar]
- Rohlik Q. T., Adams D., Kull F. C., Jr, Jacobs S. An antibody to the receptor for insulin-like growth factor I inhibits the growth of MCF-7 cells in tissue culture. Biochem Biophys Res Commun. 1987 Nov 30;149(1):276–281. doi: 10.1016/0006-291x(87)91635-4. [DOI] [PubMed] [Google Scholar]
- Steele-Perkins G., Turner J., Edman J. C., Hari J., Pierce S. B., Stover C., Rutter W. J., Roth R. A. Expression and characterization of a functional human insulin-like growth factor I receptor. J Biol Chem. 1988 Aug 15;263(23):11486–11492. [PubMed] [Google Scholar]
- Stewart A. J., Johnson M. D., May F. E., Westley B. R. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem. 1990 Dec 5;265(34):21172–21178. [PubMed] [Google Scholar]
- Stewart A. J., Westley B. R., May F. E. Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen. Br J Cancer. 1992 Oct;66(4):640–648. doi: 10.1038/bjc.1992.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thorsen T., Lahooti H., Rasmussen M., Aakvaag A. Oestradiol treatment increases the sensitivity of MCF-7 cells for the growth stimulatory effect of IGF-I. J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):537–540. doi: 10.1016/0960-0760(92)90379-w. [DOI] [PubMed] [Google Scholar]
- Toi M., Harris A. L., Bicknell R. cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo. Br J Cancer. 1993 Dec;68(6):1088–1096. doi: 10.1038/bjc.1993.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ullrich A., Gray A., Tam A. W., Yang-Feng T., Tsubokawa M., Collins C., Henzel W., Le Bon T., Kathuria S., Chen E. Insulin-like growth factor I receptor primary structure: comparison with insulin receptor suggests structural determinants that define functional specificity. EMBO J. 1986 Oct;5(10):2503–2512. doi: 10.1002/j.1460-2075.1986.tb04528.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Werner H., Woloschak M., Adamo M., Shen-Orr Z., Roberts C. T., Jr, LeRoith D. Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7451–7455. doi: 10.1073/pnas.86.19.7451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Westley B. R., May F. E. Role of insulin-like growth factors in steroid modulated proliferation. J Steroid Biochem Mol Biol. 1994 Oct;51(1-2):1–9. doi: 10.1016/0960-0760(94)90109-0. [DOI] [PubMed] [Google Scholar]
- Wiseman L. R., Johnson M. D., Wakeling A. E., Lykkesfeldt A. E., May F. E., Westley B. R. Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells. Eur J Cancer. 1993;29A(16):2256–2264. doi: 10.1016/0959-8049(93)90218-5. [DOI] [PubMed] [Google Scholar]
- Yee D., Cullen K. J., Paik S., Perdue J. F., Hampton B., Schwartz A., Lippman M. E., Rosen N. Insulin-like growth factor II mRNA expression in human breast cancer. Cancer Res. 1988 Dec 1;48(23):6691–6696. [PubMed] [Google Scholar]
- de Cupis A., Noonan D., Pirani P., Ferrera A., Clerico L., Favoni R. E. Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells. Br J Pharmacol. 1995 Nov;116(5):2391–2400. doi: 10.1111/j.1476-5381.1995.tb15085.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- van den Berg H. W., Claffie D., Boylan M., McKillen J., Lynch M., McKibben B. Expression of receptors for epidermal growth factor and insulin-like growth factor I by ZR-75-1 human breast cancer cell variants is inversely related: the effect of steroid hormones on insulin-like growth factor I receptor expression. Br J Cancer. 1996 Feb;73(4):477–481. doi: 10.1038/bjc.1996.84. [DOI] [PMC free article] [PubMed] [Google Scholar]